biotech · Locally Advanced Breast Cancer (LABC) · Mantle Cell Lymphoma
Beijing Luzhu Biopharmaceutical
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Beijing Zhifei Lvzhu is a biotech organization headquartered in CN. Primary therapeutic focus areas include Locally Advanced Breast Cancer (LABC), Mantle Cell Lymphoma, Systemic Lupus Erythematosus, Meningitis, Pneumococ
Beijing, CN HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 2
- Programs
- 7
- Drugs
- 5
- Patents
- 0
ICP-022
Phase 2 · small molecule · Systemic Lupus Erythematosus
ICP-022 for Systemic Lupus Erythematosus is a Phase 2 program (small_molecule) at Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).
Internal code ICP-CL-00109
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Systemic Lupus Erythematosus
- Status
- completed
- Trials
- 1